Bendamustine in the treatment of multiple myeloma:: Results and future perspectives

被引：18
|
作者：
Pönisch, W
Niederwieser, D
机构：
[1] Univ Leipzig, Div Hematol & Oncol, D-4103 Leipzig, Germany
[2] Univ Leipzig, E German Study Grp Hematol & Oncol, D-4103 Leipzig, Germany
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 04期
关键词：
D O I：
10.1016/S0093-7754(02)90011-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：23 / 26
页数：4
相关论文
共 50 条
  • [31] Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party
    Kim, Seok Jin
    Bang, Soo-Mee
    Choi, Yoon Seok
    Jo, Deog-Yeon
    Kim, Jin Seok
    Lee, Hyewon
    Eom, Hyeon Seok
    Yoon, Dok Hyun
    Suh, Cheolwon
    Lee, Je-Jung
    Hong, Junshik
    Lee, Jae Hoon
    Koh, Youngil
    Kim, Kihyun
    Yoon, Sung-Soo
    Min, Chang-Ki
    BLOOD RESEARCH, 2016, 51 (03) : 193 - 199
  • [32] Future agents and treatment directions in multiple myeloma
    Ocio, Enrique M.
    Mitsiades, Constantine S.
    Orlowski, Robert Z.
    Anderson, Kenneth C.
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (01) : 127 - 141
  • [33] Proteomic analysis of multiple myeloma: Current status and future perspectives
    Ge, Feng
    Bi, Li-Jun
    Tao, Sheng-Ce
    Xu, Xu-dong
    Zhang, Zhi-Ping
    Kitazato, Kaio
    Zhang, Xian-En
    PROTEOMICS CLINICAL APPLICATIONS, 2011, 5 (1-2) : 30 - 37
  • [34] Physical Rehabilitation in Multiple Myeloma - A Retrospective Analysis and Future Perspectives
    Bancos, Madalina Daiana
    Dogaru, Gabriela Bombonica
    Tipcu, Alexandru
    Salagean, Alex-Sergiu
    Orasan, Olga-Hilda
    Ciulei, George
    Milaciu, Mircea Vasile
    Hiriscau, Elisabeta Ioana
    Ciumarnean, Lorena
    BALNEO AND PRM RESEARCH JOURNAL, 2024, 15 (03):
  • [35] Editorial: Molecular Imaging in Multiple Myeloma: An Update and Future Perspectives
    Dimitrakopoulou-Strauss, Antonia
    Sachpekidis, Christos
    Lapa, Constantin
    FRONTIERS IN NUCLEAR MEDICINE, 2022, 2
  • [36] Therapeutic monoclonal antibodies for multiple myeloma: an update and future perspectives
    Yang, Jing
    Yi, Qing
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2011, 1 (01): : 22 - 33
  • [37] Bendamustine, bortezomib and prednisone for the treatment of patients with newly diagnosed multiple myeloma: results of a prospective phase 2 Spanish/PETHEMA trial
    Mateos, Maria-Victoria
    Oriol, Albert
    Rosinol, Laura
    de Arriba, Felipe
    Puig, Noemi
    Martin, Jesus
    Martinez-Lopez, Joaquin
    Asuncion Echeveste, Maria
    Sarra, Josep
    Ocio, Enrique
    Ramirez, Gemma
    Martinez, Rafael
    Palomera, Luis
    Payer, Angel
    Iglesias, Rebeca
    de la Rubia, Javier
    Alegre, Adrian
    Isabel Chinea, Ana
    Blade, Joan
    Jose Lahuerta, Juan
    San Miguel, Jesus-F.
    HAEMATOLOGICA, 2015, 100 (08) : 1096 - 1102
  • [38] BENDAMUSTINE-BASED-TREATMENT FOR HIGHLY TREATED PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Hernandez-Sanchez, A. M.
    Garcia-Sanchez, R.
    Gonzalez-Fernandez, A.
    Rivas Luque, M.
    Fernandez Fernandez, A.
    Rosell Mas, A. I.
    Caparros Miranda, I.
    Campos Garrigues, A.
    Queipo de LLano, M. P.
    Ramirez, G.
    Heiniger, A. I.
    HAEMATOLOGICA, 2014, 99 : 651 - 651
  • [39] PROGRESS AND RESULTS IN TREATMENT OF MULTIPLE-MYELOMA
    CLAUVEL, JP
    BULLETIN DU CANCER, 1972, 59 (04) : 405 - 416
  • [40] Current perspectives in the treatment of multiple myeloma - news and views
    Knop, S.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (13) : 636 - 639
12345